AMSBIO reports how the Faculty of Biological Sciences at the University of Leeds (UK) is using their specialty reagents for the production, visualization and analysis of glycans and to investigate their interactions which are instrumental to the advance of glycobiology.

Fraunhofer IZI intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza.

Under the terms of the agreement, Curamys obtains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform.

Sartorius BIA Separations and Exopharm Ltd. have announced they had entered into a formal collaboration.

Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location.

Sino Biological, Inc. is pleased to announce the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing (C4B) at its Levit Green facility in Houston, Texas USA.

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.

Ubiquigent Limited today announced the appointment of Dr. Sheelagh Frame, Chief Scientific Officer, to the Company’s Board of Directors.

Fortis Life Sciences has expanded its international presence by opening an office in Seoul, South Korea.

This year, the Biochemical Analytics Prize, endowed with 50,000 euros, will be
awarded to biochemistry professor, Dr Kai Simons and analytical chemist, Dr
Andrej Shevchenko, as well as to Professor Andreas Greinacher, a transfusion
medicine physician.